| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.26% | 63.40% | 58.59% | 55.09% | 58.62% | 61.78% | 64.13% | 62.29% | 61.13% | 62.08% | 59.47% | 61.04% |
| Operating Margin | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% | -5.19% | 2.53% | 6.71% | 9.29% | 9.65% | 10.20% | 11.58% |
| EBITDA Margin | -5.26% | -16.52% | -32.96% | -36.54% | -27.95% | -3.46% | 4.00% | 8.49% | 11.22% | 11.86% | 12.73% | 14.26% |
| Net Margin | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% | -5.01% | 2.44% | 5.25% | 6.80% | 6.39% | 6.70% | 8.09% |
| Current Ratio | 2.44 | 2.66 | 4.55 | 4.28 | 7.79 | 10.24 | 4.94 | 5.70 | 5.00 | 6.43 | 8.54 | 6.86 |
| Quick Ratio | 1.99 | 2.27 | 3.77 | 3.36 | 6.51 | 8.37 | 3.95 | 4.37 | 3.95 | 5.49 | 6.77 | 5.80 |
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE | -15.47% | -36.08% | -67.51% | -27.65% | -12.50% | -3.35% | 5.02% | 10.16% | 11.80% | 11.00% | 12.00% | 13.55% |
| ROA | -9.35% | -22.29% | -48.28% | -20.46% | -11.05% | -3.04% | 4.07% | 8.64% | 9.75% | 9.33% | 10.34% | 11.33% |
| Asset Turnover | 1.46 | 1.24 | 1.00 | 0.66 | 0.57 | 0.61 | 1.67 | 1.65 | 1.43 | 1.46 | 1.54 | 1.40 |
| Book Value / Share | 0.37 | 0.37 | 0.45 | 0.70 | 0.82 | 0.86 | 0.29 | 0.23 | 0.20 | 0.19 | 0.17 | 0.14 |
Koru Medical Systems Inc. is a medical device company that develops, manufactures, and commercializes subcutaneous infusion solutions for the subcutaneous drug delivery market in the United States and internationally. The company specializes in home and specialty infusion solutions, with a primary focus on its FREEDOM Infusion Systems, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. These devices deliver life-saving therapies to patients with chronic illnesses such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, secondary immunodeficiency disorder, and paroxysmal nocturnal hemoglobinuria. Operating at lower pressure than traditional electrical pumps, the systems balance patient tissue tolerance with accurate delivery in home care, alternate settings, emergency care, hospitals, nursing homes, and other medical facilities. Founded in 1980 and headquartered in Mahwah, New Jersey, Koru Medical Systems Inc. serves healthcare providers and patients emphasizing responsive problem-solving and patient experience in the healthcare equipment sector.